img

Global and India Medications for Canine Atopic Dermatitis Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and India Medications for Canine Atopic Dermatitis Market Report & Forecast 2024-2034

Market Analysis and InsightsGlobal and India Medications for Canine Atopic Dermatitis Market
This report focuses on global and India Medications for Canine Atopic Dermatitis market, also covers the segmentation data of other regions in regional level and county level.
The global Medications for Canine Atopic Dermatitis revenue was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period (2024-2034).
In India the Medications for Canine Atopic Dermatitis revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period (2024-2034).
The global key players of Medications for Canine Atopic Dermatitis include GlenHaven, DermaPet, DVM Pharmaceuticals, Virbac, Enzo Life Sciences, Inc., Pfizer Animal Health, Novartis Animal Health, Inc., Eli Lilly and Company and Perrigo, etc. The global five biggest players hold a share of % in 2024.
Global Medications for Canine Atopic Dermatitis Scope and Market Size
Medications for Canine Atopic Dermatitis market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Medications for Canine Atopic Dermatitis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2034.
For India market, this report focuses on the Medications for Canine Atopic Dermatitis market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in India.



By Company


GlenHaven
DermaPet
DVM Pharmaceuticals
Virbac
Enzo Life Sciences, Inc.
Pfizer Animal Health
Novartis Animal Health, Inc.
Eli Lilly and Company
Perrigo
Merck & Company
Zoetis Inc.
Toray Industries, Inc
Bayer Animal Health
Putney, Inc.
Dechra
Elanco
Kindred Biosciences
Nippon Zenyaku Kogyo Co., Ltd.
Segment by Type
Oral
External Use
Injection

Segment by Application


Veterinary Hospital
Veterinary Clinic
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Medications for Canine Atopic Dermatitis definition, global sales (volume and revenue), India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Medications for Canine Atopic Dermatitis companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Medications for Canine Atopic Dermatitis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medications for Canine Atopic Dermatitis sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion

Table of Content

1 Study Coverage
1.1 Medications for Canine Atopic Dermatitis Product Introduction
1.2 Global Medications for Canine Atopic Dermatitis Outlook 2018 VS 2024 VS 2034
1.2.1 Global Medications for Canine Atopic Dermatitis Sales in US$ Million for the Year 2018-2034
1.2.2 Global Medications for Canine Atopic Dermatitis Sales in Volume for the Year 2018-2034
1.3 India Medications for Canine Atopic Dermatitis Outlook 2018 VS 2024 VS 2034
1.3.1 India Medications for Canine Atopic Dermatitis Sales in US$ Million for the Year 2018-2034
1.3.2 India Medications for Canine Atopic Dermatitis Sales in Volume for the Year 2018-2034
1.4 Medications for Canine Atopic Dermatitis Market Size, India VS Global, 2018 VS 2024 VS 2034
1.4.1 The Market Share of India Medications for Canine Atopic Dermatitis in Global, 2018 VS 2024 VS 2034
1.4.2 The Growth Rate of Medications for Canine Atopic Dermatitis Market Size, India VS Global, 2018 VS 2024 VS 2034
1.5 Medications for Canine Atopic Dermatitis Market Dynamics
1.5.1 Medications for Canine Atopic Dermatitis Industry Trends
1.5.2 Medications for Canine Atopic Dermatitis Market Drivers
1.5.3 Medications for Canine Atopic Dermatitis Market Challenges
1.5.4 Medications for Canine Atopic Dermatitis Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Medications for Canine Atopic Dermatitis by Type
2.1 Medications for Canine Atopic Dermatitis Market Segment by Type
2.1.1 Oral
2.1.2 External Use
2.1.3 Injection
2.2 Global Medications for Canine Atopic Dermatitis Market Size by Type
2.2.1 Global Medications for Canine Atopic Dermatitis Sales in Value, by Type (2018, 2024 & 2034)
2.2.2 Global Medications for Canine Atopic Dermatitis Sales in Volume, by Type (2018, 2024 & 2034)
2.2.3 Global Medications for Canine Atopic Dermatitis Average Selling Price (ASP) by Type (2018, 2024 & 2034)
2.3 India Medications for Canine Atopic Dermatitis Market Size by Type
2.3.1 India Medications for Canine Atopic Dermatitis Sales in Value, by Type (2018, 2024 & 2034)
2.3.2 India Medications for Canine Atopic Dermatitis Sales in Volume, by Type (2018, 2024 & 2034)
2.3.3 India Medications for Canine Atopic Dermatitis Average Selling Price (ASP) by Type (2018, 2024 & 2034)
3 Medications for Canine Atopic Dermatitis by Application
3.1 Medications for Canine Atopic Dermatitis Market Segment by Application
3.1.1 Veterinary Hospital
3.1.2 Veterinary Clinic
3.2 Global Medications for Canine Atopic Dermatitis Market Size by Application
3.2.1 Global Medications for Canine Atopic Dermatitis Sales in Value, by Application (2018, 2024 & 2034)
3.2.2 Global Medications for Canine Atopic Dermatitis Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 Global Medications for Canine Atopic Dermatitis Average Selling Price (ASP) by Application (2018, 2024 & 2034)
3.3 India Medications for Canine Atopic Dermatitis Market Size by Application
3.3.1 India Medications for Canine Atopic Dermatitis Sales in Value, by Application (2018, 2024 & 2034)
3.3.2 India Medications for Canine Atopic Dermatitis Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 India Medications for Canine Atopic Dermatitis Average Selling Price (ASP) by Application (2018, 2024 & 2034)
4 Global Medications for Canine Atopic Dermatitis Competitor Landscape by Company
4.1 Global Medications for Canine Atopic Dermatitis Market Size by Company
4.1.1 Global Key Manufacturers of Medications for Canine Atopic Dermatitis, Ranked by Revenue (2024)
4.1.2 Global Medications for Canine Atopic Dermatitis Revenue by Manufacturer (2018-2023)
4.1.3 Global Medications for Canine Atopic Dermatitis Sales by Manufacturer (2018-2023)
4.1.4 Global Medications for Canine Atopic Dermatitis Price by Manufacturer (2018-2023)
4.2 Global Medications for Canine Atopic Dermatitis Concentration Ratio (CR)
4.2.1 Medications for Canine Atopic Dermatitis Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Medications for Canine Atopic Dermatitis in 2024
4.2.3 Global Medications for Canine Atopic Dermatitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Medications for Canine Atopic Dermatitis, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Medications for Canine Atopic Dermatitis, Product Offered and Application
4.5 Global Key Manufacturers of Medications for Canine Atopic Dermatitis, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India Medications for Canine Atopic Dermatitis Market Size by Company
4.7.1 Key Players of Medications for Canine Atopic Dermatitis in India, Ranked by Revenue (2024)
4.7.2 India Medications for Canine Atopic Dermatitis Revenue by Players (2018-2023)
4.7.3 India Medications for Canine Atopic Dermatitis Sales by Players (2018-2023)
5 Global Medications for Canine Atopic Dermatitis Market Size by Region
5.1 Global Medications for Canine Atopic Dermatitis Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Medications for Canine Atopic Dermatitis Market Size in Volume by Region (2018-2034)
5.2.1 Global Medications for Canine Atopic Dermatitis Sales in Volume by Region: 2018-2023
5.2.2 Global Medications for Canine Atopic Dermatitis Sales in Volume Forecast by Region (2024-2034)
5.3 Global Medications for Canine Atopic Dermatitis Market Size in Value by Region (2018-2034)
5.3.1 Global Medications for Canine Atopic Dermatitis Sales in Value by Region: 2018-2023
5.3.2 Global Medications for Canine Atopic Dermatitis Sales in Value by Region: 2024-2034
6 Americas
6.1 Americas Medications for Canine Atopic Dermatitis Market Size YoY Growth 2018-2034
6.2 Americas Medications for Canine Atopic Dermatitis Sales in Volume, by Type (2018, 2024 & 2034)
6.3 Americas Medications for Canine Atopic Dermatitis Sales in Volume, by Application (2018, 2024 & 2034)
6.4 Americas Medications for Canine Atopic Dermatitis Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 Americas Medications for Canine Atopic Dermatitis Sales in Value by Country (2018, 2024 & 2034)
6.4.2 Americas Medications for Canine Atopic Dermatitis Sales in Volume by Country (2018, 2024 & 2034)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Medications for Canine Atopic Dermatitis Market Size YoY Growth 2018-2034
7.2 EMEA Medications for Canine Atopic Dermatitis Sales in Volume, by Type (2018, 2024 & 2034)
7.3 EMEA Medications for Canine Atopic Dermatitis Sales in Volume, by Application (2018, 2024 & 2034)
7.4 EMEA Medications for Canine Atopic Dermatitis Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 EMEA Medications for Canine Atopic Dermatitis Sales in Value by Country (2018, 2024 & 2034)
7.4.2 EMEA Medications for Canine Atopic Dermatitis Sales in Volume by Country (2018, 2024 & 2034)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Medications for Canine Atopic Dermatitis Market Size YoY Growth 2018-2034
8.2 China Medications for Canine Atopic Dermatitis Sales in Volume, by Type (2018, 2024 & 2034)
8.3 China Medications for Canine Atopic Dermatitis Sales in Volume, by Application (2018, 2024 & 2034)
9 APAC
9.1 APAC Medications for Canine Atopic Dermatitis Market Size YoY Growth 2018-2034
9.2 APAC Medications for Canine Atopic Dermatitis Sales in Volume, by Type (2018, 2024 & 2034)
9.3 APAC Medications for Canine Atopic Dermatitis Sales in Volume, by Application (2018, 2024 & 2034)
9.4 APAC Medications for Canine Atopic Dermatitis Market Facts & Figures by Region (2018, 2024 & 2034)
9.4.1 APAC Medications for Canine Atopic Dermatitis Sales in Value by Region (2018, 2024 & 2034)
9.4.2 APAC Medications for Canine Atopic Dermatitis Sales in Volume by Region (2018, 2024 & 2034)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 GlenHaven
10.1.1 GlenHaven Company Information
10.1.2 GlenHaven Description and Business Overview
10.1.3 GlenHaven Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GlenHaven Medications for Canine Atopic Dermatitis Products Offered
10.1.5 GlenHaven Recent Development
10.2 DermaPet
10.2.1 DermaPet Company Information
10.2.2 DermaPet Description and Business Overview
10.2.3 DermaPet Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2018-2023)
10.2.4 DermaPet Medications for Canine Atopic Dermatitis Products Offered
10.2.5 DermaPet Recent Development
10.3 DVM Pharmaceuticals
10.3.1 DVM Pharmaceuticals Company Information
10.3.2 DVM Pharmaceuticals Description and Business Overview
10.3.3 DVM Pharmaceuticals Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2018-2023)
10.3.4 DVM Pharmaceuticals Medications for Canine Atopic Dermatitis Products Offered
10.3.5 DVM Pharmaceuticals Recent Development
10.4 Virbac
10.4.1 Virbac Company Information
10.4.2 Virbac Description and Business Overview
10.4.3 Virbac Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Virbac Medications for Canine Atopic Dermatitis Products Offered
10.4.5 Virbac Recent Development
10.5 Enzo Life Sciences, Inc.
10.5.1 Enzo Life Sciences, Inc. Company Information
10.5.2 Enzo Life Sciences, Inc. Description and Business Overview
10.5.3 Enzo Life Sciences, Inc. Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Enzo Life Sciences, Inc. Medications for Canine Atopic Dermatitis Products Offered
10.5.5 Enzo Life Sciences, Inc. Recent Development
10.6 Pfizer Animal Health
10.6.1 Pfizer Animal Health Company Information
10.6.2 Pfizer Animal Health Description and Business Overview
10.6.3 Pfizer Animal Health Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Pfizer Animal Health Medications for Canine Atopic Dermatitis Products Offered
10.6.5 Pfizer Animal Health Recent Development
10.7 Novartis Animal Health, Inc.
10.7.1 Novartis Animal Health, Inc. Company Information
10.7.2 Novartis Animal Health, Inc. Description and Business Overview
10.7.3 Novartis Animal Health, Inc. Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Novartis Animal Health, Inc. Medications for Canine Atopic Dermatitis Products Offered
10.7.5 Novartis Animal Health, Inc. Recent Development
10.8 Eli Lilly and Company
10.8.1 Eli Lilly and Company Company Information
10.8.2 Eli Lilly and Company Description and Business Overview
10.8.3 Eli Lilly and Company Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Eli Lilly and Company Medications for Canine Atopic Dermatitis Products Offered
10.8.5 Eli Lilly and Company Recent Development
10.9 Perrigo
10.9.1 Perrigo Company Information
10.9.2 Perrigo Description and Business Overview
10.9.3 Perrigo Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Perrigo Medications for Canine Atopic Dermatitis Products Offered
10.9.5 Perrigo Recent Development
10.10 Merck & Company
10.10.1 Merck & Company Company Information
10.10.2 Merck & Company Description and Business Overview
10.10.3 Merck & Company Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Merck & Company Medications for Canine Atopic Dermatitis Products Offered
10.10.5 Merck & Company Recent Development
10.11 Zoetis Inc.
10.11.1 Zoetis Inc. Company Information
10.11.2 Zoetis Inc. Description and Business Overview
10.11.3 Zoetis Inc. Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Zoetis Inc. Medications for Canine Atopic Dermatitis Products Offered
10.11.5 Zoetis Inc. Recent Development
10.12 Toray Industries, Inc
10.12.1 Toray Industries, Inc Company Information
10.12.2 Toray Industries, Inc Description and Business Overview
10.12.3 Toray Industries, Inc Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Toray Industries, Inc Medications for Canine Atopic Dermatitis Products Offered
10.12.5 Toray Industries, Inc Recent Development
10.13 Bayer Animal Health
10.13.1 Bayer Animal Health Company Information
10.13.2 Bayer Animal Health Description and Business Overview
10.13.3 Bayer Animal Health Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Bayer Animal Health Medications for Canine Atopic Dermatitis Products Offered
10.13.5 Bayer Animal Health Recent Development
10.14 Putney, Inc.
10.14.1 Putney, Inc. Company Information
10.14.2 Putney, Inc. Description and Business Overview
10.14.3 Putney, Inc. Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Putney, Inc. Medications for Canine Atopic Dermatitis Products Offered
10.14.5 Putney, Inc. Recent Development
10.15 Dechra
10.15.1 Dechra Company Information
10.15.2 Dechra Description and Business Overview
10.15.3 Dechra Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Dechra Medications for Canine Atopic Dermatitis Products Offered
10.15.5 Dechra Recent Development
10.16 Elanco
10.16.1 Elanco Company Information
10.16.2 Elanco Description and Business Overview
10.16.3 Elanco Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Elanco Medications for Canine Atopic Dermatitis Products Offered
10.16.5 Elanco Recent Development
10.17 Kindred Biosciences
10.17.1 Kindred Biosciences Company Information
10.17.2 Kindred Biosciences Description and Business Overview
10.17.3 Kindred Biosciences Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Kindred Biosciences Medications for Canine Atopic Dermatitis Products Offered
10.17.5 Kindred Biosciences Recent Development
10.18 Nippon Zenyaku Kogyo Co., Ltd.
10.18.1 Nippon Zenyaku Kogyo Co., Ltd. Company Information
10.18.2 Nippon Zenyaku Kogyo Co., Ltd. Description and Business Overview
10.18.3 Nippon Zenyaku Kogyo Co., Ltd. Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Nippon Zenyaku Kogyo Co., Ltd. Medications for Canine Atopic Dermatitis Products Offered
10.18.5 Nippon Zenyaku Kogyo Co., Ltd. Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Medications for Canine Atopic Dermatitis Industry Chain Analysis
11.2 Medications for Canine Atopic Dermatitis Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Medications for Canine Atopic Dermatitis Production Mode & Process
11.4 Medications for Canine Atopic Dermatitis Sales and Marketing
11.4.1 Medications for Canine Atopic Dermatitis Sales Channels
11.4.2 Medications for Canine Atopic Dermatitis Distributors
11.5 Medications for Canine Atopic Dermatitis Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Medications for Canine Atopic Dermatitis CAGR in Value, India VS Global, 2018 VS 2024 VS 2034
Table 2. Medications for Canine Atopic Dermatitis Market Trends
Table 3. Medications for Canine Atopic Dermatitis Market Drivers
Table 4. Medications for Canine Atopic Dermatitis Market Challenges
Table 5. Medications for Canine Atopic Dermatitis Market Restraints
Table 6. Global Medications for Canine Atopic Dermatitis Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. India Medications for Canine Atopic Dermatitis Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Medications for Canine Atopic Dermatitis Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. India Medications for Canine Atopic Dermatitis Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Manufacturers of Medications for Canine Atopic Dermatitis, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Medications for Canine Atopic Dermatitis Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Medications for Canine Atopic Dermatitis Revenue Share by Manufacturer, 2018-2023
Table 13. Global Medications for Canine Atopic Dermatitis Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global Medications for Canine Atopic Dermatitis Sales Share by Manufacturer, 2018-2023
Table 15. Global Medications for Canine Atopic Dermatitis Price by Manufacturer (2018-2023) & (US$/Unit)
Table 16. Global Medications for Canine Atopic Dermatitis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Medications for Canine Atopic Dermatitis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medications for Canine Atopic Dermatitis as of 2024)
Table 18. Global Key Manufacturers of Medications for Canine Atopic Dermatitis, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Medications for Canine Atopic Dermatitis, Product Offered and Application
Table 20. Global Key Manufacturers of Medications for Canine Atopic Dermatitis, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Medications for Canine Atopic Dermatitis in India, Ranked by Revenue (2024) & (US$ million)
Table 23. India Medications for Canine Atopic Dermatitis Revenue by Players, (US$ Million), (2018-2023)
Table 24. India Medications for Canine Atopic Dermatitis Revenue Share by Players, (2018-2023)
Table 25. India Medications for Canine Atopic Dermatitis Sales by Players, (K Units), (2018-2023)
Table 26. India Medications for Canine Atopic Dermatitis Sales Share by Players, (2018-2023)
Table 27. Global Medications for Canine Atopic Dermatitis Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 28. Global Medications for Canine Atopic Dermatitis Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global Medications for Canine Atopic Dermatitis Sales in Volume Forecast by Region (2024-2034) & (K Units)
Table 30. Global Medications for Canine Atopic Dermatitis Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Medications for Canine Atopic Dermatitis Sales in Value Forecast by Region (2024-2034) & (US$ Million)
Table 32. Americas Medications for Canine Atopic Dermatitis Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. Americas Medications for Canine Atopic Dermatitis Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Medications for Canine Atopic Dermatitis Sales in Value by Country (2024-2034) & (US$ Million)
Table 35. Americas Medications for Canine Atopic Dermatitis Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas Medications for Canine Atopic Dermatitis Sales in Volume by Country (2024-2034) & (K Units)
Table 37. EMEA Medications for Canine Atopic Dermatitis Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. EMEA Medications for Canine Atopic Dermatitis Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Medications for Canine Atopic Dermatitis Sales in Value by Country (2024-2034) & (US$ Million)
Table 40. EMEA Medications for Canine Atopic Dermatitis Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA Medications for Canine Atopic Dermatitis Sales in Volume by Country (2024-2034) & (K Units)
Table 42. APAC Medications for Canine Atopic Dermatitis Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. APAC Medications for Canine Atopic Dermatitis Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Medications for Canine Atopic Dermatitis Sales in Value by Country (2024-2034) & (US$ Million)
Table 45. APAC Medications for Canine Atopic Dermatitis Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC Medications for Canine Atopic Dermatitis Sales in Volume by Country (2024-2034) & (K Units)
Table 47. GlenHaven Company Information
Table 48. GlenHaven Description and Business Overview
Table 49. GlenHaven Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 50. GlenHaven Medications for Canine Atopic Dermatitis Product
Table 51. GlenHaven Recent Development
Table 52. DermaPet Company Information
Table 53. DermaPet Description and Business Overview
Table 54. DermaPet Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 55. DermaPet Medications for Canine Atopic Dermatitis Product
Table 56. DermaPet Recent Development
Table 57. DVM Pharmaceuticals Company Information
Table 58. DVM Pharmaceuticals Description and Business Overview
Table 59. DVM Pharmaceuticals Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 60. DVM Pharmaceuticals Medications for Canine Atopic Dermatitis Product
Table 61. DVM Pharmaceuticals Recent Development
Table 62. Virbac Company Information
Table 63. Virbac Description and Business Overview
Table 64. Virbac Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 65. Virbac Medications for Canine Atopic Dermatitis Product
Table 66. Virbac Recent Development
Table 67. Enzo Life Sciences, Inc. Company Information
Table 68. Enzo Life Sciences, Inc. Description and Business Overview
Table 69. Enzo Life Sciences, Inc. Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 70. Enzo Life Sciences, Inc. Medications for Canine Atopic Dermatitis Product
Table 71. Enzo Life Sciences, Inc. Recent Development
Table 72. Pfizer Animal Health Company Information
Table 73. Pfizer Animal Health Description and Business Overview
Table 74. Pfizer Animal Health Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 75. Pfizer Animal Health Medications for Canine Atopic Dermatitis Product
Table 76. Pfizer Animal Health Recent Development
Table 77. Novartis Animal Health, Inc. Company Information
Table 78. Novartis Animal Health, Inc. Description and Business Overview
Table 79. Novartis Animal Health, Inc. Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 80. Novartis Animal Health, Inc. Medications for Canine Atopic Dermatitis Product
Table 81. Novartis Animal Health, Inc. Recent Development
Table 82. Eli Lilly and Company Company Information
Table 83. Eli Lilly and Company Description and Business Overview
Table 84. Eli Lilly and Company Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Eli Lilly and Company Medications for Canine Atopic Dermatitis Product
Table 86. Eli Lilly and Company Recent Development
Table 87. Perrigo Company Information
Table 88. Perrigo Description and Business Overview
Table 89. Perrigo Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. Perrigo Medications for Canine Atopic Dermatitis Product
Table 91. Perrigo Recent Development
Table 92. Merck & Company Company Information
Table 93. Merck & Company Description and Business Overview
Table 94. Merck & Company Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. Merck & Company Medications for Canine Atopic Dermatitis Product
Table 96. Merck & Company Recent Development
Table 97. Zoetis Inc. Company Information
Table 98. Zoetis Inc. Description and Business Overview
Table 99. Zoetis Inc. Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. Zoetis Inc. Medications for Canine Atopic Dermatitis Product
Table 101. Zoetis Inc. Recent Development
Table 102. Toray Industries, Inc Company Information
Table 103. Toray Industries, Inc Description and Business Overview
Table 104. Toray Industries, Inc Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. Toray Industries, Inc Medications for Canine Atopic Dermatitis Product
Table 106. Toray Industries, Inc Recent Development
Table 107. Bayer Animal Health Company Information
Table 108. Bayer Animal Health Description and Business Overview
Table 109. Bayer Animal Health Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. Bayer Animal Health Medications for Canine Atopic Dermatitis Product
Table 111. Bayer Animal Health Recent Development
Table 112. Putney, Inc. Company Information
Table 113. Putney, Inc. Description and Business Overview
Table 114. Putney, Inc. Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. Putney, Inc. Medications for Canine Atopic Dermatitis Product
Table 116. Putney, Inc. Recent Development
Table 117. Dechra Company Information
Table 118. Dechra Description and Business Overview
Table 119. Dechra Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. Dechra Medications for Canine Atopic Dermatitis Product
Table 121. Dechra Recent Development
Table 122. Elanco Company Information
Table 123. Elanco Description and Business Overview
Table 124. Elanco Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. Elanco Medications for Canine Atopic Dermatitis Product
Table 126. Elanco Recent Development
Table 127. Kindred Biosciences Company Information
Table 128. Kindred Biosciences Description and Business Overview
Table 129. Kindred Biosciences Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 130. Kindred Biosciences Medications for Canine Atopic Dermatitis Product
Table 131. Kindred Biosciences Recent Development
Table 132. Nippon Zenyaku Kogyo Co., Ltd. Company Information
Table 133. Nippon Zenyaku Kogyo Co., Ltd. Description and Business Overview
Table 134. Nippon Zenyaku Kogyo Co., Ltd. Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 135. Nippon Zenyaku Kogyo Co., Ltd. Medications for Canine Atopic Dermatitis Product
Table 136. Nippon Zenyaku Kogyo Co., Ltd. Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Medications for Canine Atopic Dermatitis Customers List
Table 140. Medications for Canine Atopic Dermatitis Distributors List
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Medications for Canine Atopic Dermatitis Product Picture
Figure 2. Global Medications for Canine Atopic Dermatitis Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Medications for Canine Atopic Dermatitis Market Size 2018-2034 (US$ Million)
Figure 4. Global Medications for Canine Atopic Dermatitis Sales 2018-2034 (K Units)
Figure 5. India Medications for Canine Atopic Dermatitis Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 6. India Medications for Canine Atopic Dermatitis Market Size 2018-2034 (US$ Million)
Figure 7. India Medications for Canine Atopic Dermatitis Sales 2018-2034 (K Units)
Figure 8. India Medications for Canine Atopic Dermatitis Market Share in Global, in Value (US$ Million) 2018-2034
Figure 9. India Medications for Canine Atopic Dermatitis Market Share in Global, in Volume (K Units) 2018-2034
Figure 10. Medications for Canine Atopic Dermatitis Report Years Considered
Figure 11. Product Picture of Oral
Figure 12. Product Picture of External Use
Figure 13. Product Picture of Injection
Figure 14. Global Medications for Canine Atopic Dermatitis Market Share by Type in 2024 & 2034
Figure 15. Global Medications for Canine Atopic Dermatitis Sales in Value by Type (2018-2034) & (US$ Million)
Figure 16. Global Medications for Canine Atopic Dermatitis Sales Market Share in Value by Type (2018-2034)
Figure 17. Global Medications for Canine Atopic Dermatitis Sales by Type (2018-2034) & (K Units)
Figure 18. Global Medications for Canine Atopic Dermatitis Sales Market Share in Volume by Type (2018-2034)
Figure 19. Global Medications for Canine Atopic Dermatitis Price by Type (2018-2034) & (US$/Unit)
Figure 20. India Medications for Canine Atopic Dermatitis Market Share by Type in 2024 & 2034
Figure 21. India Medications for Canine Atopic Dermatitis Sales in Value by Type (2018-2034) & (US$ Million)
Figure 22. India Medications for Canine Atopic Dermatitis Sales Market Share in Value by Type (2018-2034)
Figure 23. India Medications for Canine Atopic Dermatitis Sales by Type (2018-2034) & (K Units)
Figure 24. India Medications for Canine Atopic Dermatitis Sales Market Share in Volume by Type (2018-2034)
Figure 25. India Medications for Canine Atopic Dermatitis Price by Type (2018-2034) & (US$/Unit)
Figure 26. Product Picture of Veterinary Hospital
Figure 27. Product Picture of Veterinary Clinic
Figure 28. Global Medications for Canine Atopic Dermatitis Market Share by Application in 2024 & 2034
Figure 29. Global Medications for Canine Atopic Dermatitis Sales in Value by Application (2018-2034) & (US$ Million)
Figure 30. Global Medications for Canine Atopic Dermatitis Sales Market Share in Value by Application (2018-2034)
Figure 31. Global Medications for Canine Atopic Dermatitis Sales by Application (2018-2034) & (K Units)
Figure 32. Global Medications for Canine Atopic Dermatitis Sales Market Share in Volume by Application (2018-2034)
Figure 33. Global Medications for Canine Atopic Dermatitis Price by Application (2018-2034) & (US$/Unit)
Figure 34. India Medications for Canine Atopic Dermatitis Market Share by Application in 2024 & 2034
Figure 35. India Medications for Canine Atopic Dermatitis Sales in Value by Application (2018-2034) & (US$ Million)
Figure 36. India Medications for Canine Atopic Dermatitis Sales Market Share in Value by Application (2018-2034)
Figure 37. India Medications for Canine Atopic Dermatitis Sales by Application (2018-2034) & (K Units)
Figure 38. India Medications for Canine Atopic Dermatitis Sales Market Share in Volume by Application (2018-2034)
Figure 39. India Medications for Canine Atopic Dermatitis Price by Application (2018-2034) & (US$/Unit)
Figure 40. Americas Medications for Canine Atopic Dermatitis Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 41. Americas Medications for Canine Atopic Dermatitis Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 42. Americas Medications for Canine Atopic Dermatitis Sales by Type (2018-2034) & (K Units)
Figure 43. Americas Medications for Canine Atopic Dermatitis Sales Market Share in Volume by Type (2018-2034)
Figure 44. Americas Medications for Canine Atopic Dermatitis Sales by Application (2018-2034) & (K Units)
Figure 45. Americas Medications for Canine Atopic Dermatitis Sales Market Share in Volume by Application (2018-2034)
Figure 46. United States Medications for Canine Atopic Dermatitis Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 47. Canada Medications for Canine Atopic Dermatitis Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 48. Mexico Medications for Canine Atopic Dermatitis Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 49. Brazil Medications for Canine Atopic Dermatitis Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 50. EMEA Medications for Canine Atopic Dermatitis Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 51. EMEA Medications for Canine Atopic Dermatitis Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 52. EMEA Medications for Canine Atopic Dermatitis Sales by Type (2018-2034) & (K Units)
Figure 53. EMEA Medications for Canine Atopic Dermatitis Sales Market Share in Volume by Type (2018-2034)
Figure 54. EMEA Medications for Canine Atopic Dermatitis Sales by Application (2018-2034) & (K Units)
Figure 55. EMEA Medications for Canine Atopic Dermatitis Sales Market Share in Volume by Application (2018-2034)
Figure 56. Europe Medications for Canine Atopic Dermatitis Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 57. Middle East Medications for Canine Atopic Dermatitis Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 58. Africa Medications for Canine Atopic Dermatitis Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 59. China Medications for Canine Atopic Dermatitis Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 60. China Medications for Canine Atopic Dermatitis Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 61. China Medications for Canine Atopic Dermatitis Sales by Type (2018-2034) & (K Units)
Figure 62. China Medications for Canine Atopic Dermatitis Sales Market Share in Volume by Type (2018-2034)
Figure 63. China Medications for Canine Atopic Dermatitis Sales by Application (2018-2034) & (K Units)
Figure 64. China Medications for Canine Atopic Dermatitis Sales Market Share in Volume by Application (2018-2034)
Figure 65. APAC Medications for Canine Atopic Dermatitis Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 66. APAC Medications for Canine Atopic Dermatitis Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 67. APAC Medications for Canine Atopic Dermatitis Sales by Type (2018-2034) & (K Units)
Figure 68. APAC Medications for Canine Atopic Dermatitis Sales Market Share in Volume by Type (2018-2034)
Figure 69. APAC Medications for Canine Atopic Dermatitis Sales by Application (2018-2034) & (K Units)
Figure 70. APAC Medications for Canine Atopic Dermatitis Sales Market Share in Volume by Application (2018-2034)
Figure 71. Japan Medications for Canine Atopic Dermatitis Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 72. South Korea Medications for Canine Atopic Dermatitis Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 73. China Taiwan Medications for Canine Atopic Dermatitis Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 74. Southeast Asia Medications for Canine Atopic Dermatitis Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 75. India Medications for Canine Atopic Dermatitis Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 76. Medications for Canine Atopic Dermatitis Value Chain
Figure 77. Medications for Canine Atopic Dermatitis Production Process
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed